Alzheimer’s Drug Discovery Foundation Funds Edunn Biotechnology to Develop Treatment for Alzheimer’s Disease

The Alzheimer’s Drug Discovery Foundation (ADDF) announced today that it is providing a grant of 0,000 to Edunn Biotechnology, Inc., an early stage company dedicated to developing a novel class of drugs to treat and prevent Alzheimer’s disease (AD).

Edunn’s lead drug candidate, EDN-OL1, is an …

Comments are closed.